Ventyx Biosciences Inc (VTYX)’s Ratio Roundup: Key Metrics for Trailing Twelve Months

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

As of close of business last night, Ventyx Biosciences Inc’s stock clocked out at $3.29, down -37.78% from its previous closing price of $5.28. In other words, the price has decreased by -$37.78 from its previous closing price. On the day, 6.7 million shares were traded. VTYX stock price reached its highest trading level at $4.82 during the session, while it also had its lowest trading level at $3.03.


To gain a deeper understanding of VTYX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 22.00 and its Current Ratio is at 22.00. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on March 12, 2024, Upgraded its rating to Overweight and sets its target price to $16 from $7 previously.

On March 12, 2024, Oppenheimer Upgraded its rating to Outperform which previously was Perform but kept the price unchanged to $12.

Wells Fargo Downgraded its Overweight to Equal Weight on November 07, 2023, whereas the target price for the stock was revised from $77 to $8.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 02 ’24 when Mohan Raju sold 4,312 shares for $5.40 per share. The transaction valued at 23,299 led to the insider holds 1,578,250 shares of the business.

Krueger Christopher W sold 1,651 shares of VTYX for $8,921 on Apr 02 ’24. The CHIEF BUSINESS OFFICER now owns 284,999 shares after completing the transaction at $5.40 per share. On Apr 02 ’24, another insider, Nuss John, who serves as the CHIEF SCIENTIFIC OFFICER of the company, sold 1,651 shares for $5.40 each. As a result, the insider received 8,921 and left with 264,998 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VTYX now has a Market Capitalization of 372236512 and an Enterprise Value of -59515088.

Stock Price History:

Over the past 52 weeks, VTYX has reached a high of $40.58, while it has fallen to a 52-week low of $1.87. The 50-Day Moving Average of the stock is -29.97%, while the 200-Day Moving Average is calculated to be -68.40%.

Shares Statistics:

It appears that VTYX traded 1.36M shares on average per day over the past three months and 1482530 shares per day over the past ten days. A total of 59.24M shares are outstanding, with a floating share count of 53.89M. Insiders hold about 23.56% of the company’s shares, while institutions hold 74.34% stake in the company. Shares short for VTYX as of 1715731200 were 8306506 with a Short Ratio of 6.12, compared to 1713139200 on 8376045. Therefore, it implies a Short% of Shares Outstanding of 8306506 and a Short% of Float of 13.8.

Most Popular